Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids for Bipolar Disorder
NCT00001146Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- Oct 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Epadel in bipolar disorder (BD), sponsored by National Institute of Mental Health. Started Oct 1999; status: completed.
02
Drugs
Epadel
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00001146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001146.